Pharma-Bio Serv Files 10-Q for the Quarter Ended July 31, 2020
Pharma-Bio Serv, Inc. (OTCQB:PBSV) filed its Quarterly Report on Form 10-Q for the quarter ended July 31, 2020. The report highlights the company's ongoing compliance and consulting services to various industries, including pharmaceutical and biotechnology. Additionally, the earnings announcement has been published on the company’s website. Forward-looking statements in the report indicate potential business risks and market uncertainties, including challenges posed by the COVID-19 pandemic. Investors can access key documents under the Investor tab on the company's site.
- Company continues to provide compliance and consulting services across multiple industries.
- Earnings announcement provides transparency to investors and stakeholders.
- Forward-looking statements mention significant risks and uncertainties related to COVID-19 and market conditions.
DORADO, PUERTO RICO / ACCESSWIRE / September 14, 2020 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced it has filed its Quarterly Report on Form 10-Q for the quarter ended July 31, 2020. The Company has also posted its earnings announcement for the quarter ended July 31, 2020 on its corporate website. You can access both the Form 10-Q and the earnings announcement under the Investor tab at www.pharmabioserv.com using the following links:
Form 10-Q - http://irdirect.net/PBSV/sec_filings
Earnings Announcement - http://irdirect.net/PBSV/press_releases
About Pharma-Bio Serv, Inc.
Pharma-Bio Serv is a compliance, project management, and technology transfer support consulting firm, headquartered in Puerto Rico, servicing the Puerto Rico, United States, Europe and Brazil markets. Pharma-Bio Serv's core business is FDA and international agencies regulatory compliance consulting related services. The Company's global team includes leading engineering and life science professionals, quality assurance managers and directors.
Forward-Looking Statements
The information in the Company's Form 10-Q and earnings announcement contains "forward-looking statements" within the meaning of the U.S. federal securities laws, which statements may include information regarding the plans, intentions, expectations, future financial performance, or future operating performance of Pharma-Bio Serv. Forward-looking statements are based on the expectations, estimates, or projections of management as of the respective dates of the Form 10-Q and the earnings announcement. Although Pharma-Bio Serv's management believes these expectations, estimates, or projections to be reasonable as of the respective dates of the Form 10-Q and the earnings announcement, forward-looking statements are inherently subject to significant business risks, economic uncertainties, including any impacts of the coronavirus (COVID-19) pandemic, and competitive uncertainties, or other contingencies, which could cause its actual results or performance to differ materially from what may be expressed or implied in the forward-looking statements. Important factors that could cause Pharma-Bio Serv's actual results or performance to differ materially from the forward-looking statements include those set forth in the "Risk Factors" section of Pharma-Bio Serv's Annual Report on Form 10-K for the year ended October 31, 2019, and in its other filings with the Securities and Exchange Commission, which filings are available on www.sec.gov. Pharma-Bio Serv disclaims any intention or obligation to update or revise any forward-looking statements to reflect subsequent events and circumstances, except to the extent required by applicable law.
Company Contact:
Pedro J. Lasanta
Chief Financial Officer
787 278 2709
SOURCE: Pharma-Bio Serv, Inc.
View source version on accesswire.com:
https://www.accesswire.com/606091/Pharma-Bio-Serv-Files-10-Q-for-the-Quarter-Ended-July-31-2020
FAQ
What did Pharma-Bio Serv announce on September 14, 2020?
Where can I find Pharma-Bio Serv's earnings announcement?
What are the risks mentioned by Pharma-Bio Serv in their latest report?
What is the stock symbol for Pharma-Bio Serv?
What type of consulting services does Pharma-Bio Serv provide?
